New COVID Vaccine Eris, Anticipated to become available next month, a fresh COVID vaccine is on the horizon. However, experts in healthcare and analysis predict a relatively muted reception, even as the country experiences a rise in hospitalizations due to “Eris,” a variant of the Omicron form of the coronavirus.
Certain public health experts hold hope that Americans will embrace the new vaccine in a manner similar to receiving a flu shot. Nevertheless, the demand for the vaccine has seen a sharp decline since its initial introduction in 2021. With more than 240 million individuals in the U.S., accounting for 73% of the population, having already received at least one shot, this trend has become evident.